Ying Bai

486 total citations
32 papers, 342 citations indexed

About

Ying Bai is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ying Bai has authored 32 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ying Bai's work include Cancer-related molecular mechanisms research (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Circular RNAs in diseases (4 papers). Ying Bai is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Circular RNAs in diseases (4 papers). Ying Bai collaborates with scholars based in China, United States and Romania. Ying Bai's co-authors include Ling Xu, Cuili Zhang, Pengyan Wu, Zhichao Zhang, Chunying Duan, Hong Fang, Jian Wang, Jun Wang, Shuhang Wang and Dawei Wu and has published in prestigious journals such as PLoS ONE, Biochemistry and Journal of The Electrochemical Society.

In The Last Decade

Ying Bai

27 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Bai China 12 111 71 67 40 29 32 342
Evan A. Thackaberry United States 14 167 1.5× 33 0.5× 71 1.1× 22 0.6× 35 1.2× 29 574
Zhichuan Zhu China 16 378 3.4× 57 0.8× 85 1.3× 36 0.9× 23 0.8× 26 687
Yichen Li United States 7 183 1.6× 40 0.6× 53 0.8× 57 1.4× 12 0.4× 12 346
Timuçin Avşar Türkiye 12 121 1.1× 34 0.5× 26 0.4× 12 0.3× 15 0.5× 35 289
Baoyi Zhang China 8 193 1.7× 70 1.0× 92 1.4× 62 1.6× 13 0.4× 35 446
Esther Kim United States 11 354 3.2× 117 1.6× 72 1.1× 63 1.6× 30 1.0× 19 609
Michael Fernandes United States 9 180 1.6× 122 1.7× 57 0.9× 45 1.1× 7 0.2× 21 481
Wen‐Hsin Liu Taiwan 16 319 2.9× 74 1.0× 103 1.5× 24 0.6× 8 0.3× 31 541
Markéta Sztalmachová Czechia 14 200 1.8× 84 1.2× 76 1.1× 33 0.8× 5 0.2× 19 532
Xiaoqian Huang China 13 216 1.9× 29 0.4× 82 1.2× 18 0.5× 8 0.3× 28 496

Countries citing papers authored by Ying Bai

Since Specialization
Citations

This map shows the geographic impact of Ying Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Bai more than expected).

Fields of papers citing papers by Ying Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Bai. The network helps show where Ying Bai may publish in the future.

Co-authorship network of co-authors of Ying Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Bai. A scholar is included among the top collaborators of Ying Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Bai. Ying Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Biao, et al.. (2025). Screening and validation of key microRNAs regulating muscle development in Hanper sheep. PLoS ONE. 20(6). e0325054–e0325054.
5.
Zhao, Weihong, et al.. (2024). Novel biomarkers of inflammation-associated immunity in cervical cancer. Frontiers in Oncology. 14. 1351736–1351736. 3 indexed citations
6.
Deng, Lei, et al.. (2024). Adverse reactions of immune checkpoint inhibitors combined with angiogenesis inhibitors: A pharmacovigilance analysis of drug–drug interactions. International Journal of Immunopathology and Pharmacology. 38. 1210525486–1210525486. 2 indexed citations
7.
Bai, Ying, et al.. (2023). Transient receptor potential M2 channel in the hypothalamic preoptic area and its impact on thermoregulation during menopause. Annals of Anatomy - Anatomischer Anzeiger. 250. 152132–152132. 2 indexed citations
8.
Liu, Yafeng, Jiawei Zhou, Jing Wu, et al.. (2023). Construction and Validation of a Novel Immune-Related Gene Pairs-Based Prognostic Model in Lung Adenocarcinoma. Cancer Control. 30. 2905568275–2905568275.
9.
Bai, Ying, Yafeng Liu, Jing Wu, et al.. (2023). CD4 levels and NSCLC metastasis: the benefits of maintaining moderate levels. Journal of Cancer Research and Clinical Oncology. 149(18). 16827–16836. 2 indexed citations
10.
Liu, Conghui, Ying Bai, Lehe Yang, et al.. (2023). Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway. Aging. 15(16). 8258–8274. 11 indexed citations
11.
Bai, Ying, Yihan Chen, Qiaofeng Jin, et al.. (2023). Platelet membrane-derived biomimetic microbubbles with enhanced targeting ability for the early detection of myocardial ischemia-reperfusion injury. Colloids and Surfaces B Biointerfaces. 234. 113680–113680. 4 indexed citations
12.
Liu, Ximing, Ying Bai, Ran Cui, et al.. (2022). Integrated Analysis of the ceRNA Network and M-7474 Function in Testosterone-Mediated Fat Deposition in Pigs. Genes. 13(4). 668–668. 3 indexed citations
13.
Liu, Ximing, Ying Bai, Ran Cui, et al.. (2022). Sus_circPAPPA2 Regulates Fat Deposition in Castrated Pigs through the miR-2366/GK Pathway. Biomolecules. 12(6). 753–753. 14 indexed citations
14.
Liu, Min, Yulin Peng, Ying Bai, et al.. (2022). MiR-146b-5p/TRAF6 axis is essential for Ginkgo biloba L. extract GBE to attenuate LPS-induced neuroinflammation. Frontiers in Pharmacology. 13. 978587–978587. 7 indexed citations
15.
Shi, Jie, Zhiyu Wang, Junping Zhang, et al.. (2021). Genomic Landscape and Tumor Mutational Burden Determination of Circulating Tumor DNA in Over 5,000 Chinese Patients with Lung Cancer. Clinical Cancer Research. 27(22). 6184–6196. 9 indexed citations
16.
Bai, Ying, et al.. (2021). Discovery of novel and potent PARP/PI3K dual inhibitors for the treatment of cancer. European Journal of Medicinal Chemistry. 217. 113357–113357. 25 indexed citations
17.
Tang, Wei, et al.. (2020). Molecular evidence of impaired iron metabolism and its association with Parkinson's disease progression. 3 Biotech. 10(4). 173–173. 7 indexed citations
18.
Xu, Ling, Cuili Zhang, Dan He, et al.. (2020). Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis. Life Sciences. 253. 117747–117747. 26 indexed citations
19.
Li, Ning, Huiyao Huang, Dawei Wu, et al.. (2019). Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review. The Lancet Oncology. 20(11). e619–e626. 63 indexed citations
20.
Guo, Haoran, Enmin Ding, Ying Bai, et al.. (2017). Association of genetic variations in FOXO3 gene with susceptibility to noise induced hearing loss in a Chinese population. PLoS ONE. 12(12). e0189186–e0189186. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026